Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04891328 · ClinicalTrials.gov registry record

Experience With a Pediatric Summer Intensive Therapy Program

A clinical trial of Neurodevelopmental Disorders, sponsored by University of Missouri-Columbia.

Completed
Registry status
13
Enrollment target
1
Study location

NCT04891328 is a study of Neurodevelopmental Disorders that has completed, run by University of Missouri-Columbia. The registered enrollment target is 13 participants, below the 581-participant average among 27 other Neurodevelopmental Disorders trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04891328, a study of Neurodevelopmental Disorders, has completed, sponsored by University of Missouri-Columbia.

COMPLETED
Registry status
13 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to explore the lived experiences of children with neurodevelopmental diagnoses and their caregivers with an intensive model of therapy. Children will receive usual care during the summer intensive program and the investigators will access medical records to assess effectiveness. Children and caregivers will also be asked to participate in semi-structured interviews upon the completion of the episode of care.

Interventions

  • OTHER Intensive therapy program

Study Locations (1)

Missouri

  • University of Missouri Healthcare Children's Therapy Center - Columbia

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2021-05-24
Est. Completion 2021-10-01

Sponsor

University of Missouri-Columbia

291 total trials

What the Registry Record Tells You About NCT04891328

The ClinicalTrials.gov registry entry for NCT04891328 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 581-participant average among 27 other Neurodevelopmental Disorders trials with a reported enrollment target (98% lower). The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Neurodevelopmental Disorders appearing as the primary indexed condition, and to 1 intervention - of which Intensive therapy program is the first listed.

NCT04891328 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT04891328 about?

NCT04891328 is a clinical study titled "Experience With a Pediatric Summer Intensive Therapy Program". The purpose of this study is to explore the lived experiences of children with neurodevelopmental diagnoses and their caregivers with an intensive model of therapy. Children will receive usual care during the summer intensive program and the investigators will access medical records to assess effect...

What is the current status of trial NCT04891328?

This trial is currently completed. The enrollment target is 13 participants. The study started on 2021-05-24. Estimated completion is 2021-10-01.

What conditions does trial NCT04891328 study?

This clinical trial studies the following conditions: Neurodevelopmental Disorders.

What interventions are being tested in trial NCT04891328?

The interventions under investigation include: Intensive therapy program (OTHER).

Who is sponsoring clinical trial NCT04891328?

This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04891328 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Neurodevelopmental Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.